Vallette-Kasic Sophie, Couture Catherine, Balsalobre Aurelio, Gauthier Yves, Metherell Louise, Dattani Mehul, Drouin Jacques
Laboratoire de génétique moléculaire, Institut de recherches cliniques de Montréal, 110, avenue des Pins Ouest, Montréal, QC, Canada H2W 1R7.
J Clin Endocrinol Metab. 2007 Oct;92(10):3991-9. doi: 10.1210/jc.2007-0284. Epub 2007 Jul 24.
Tpit is a T-box transcription factor important for terminal differentiation of pituitary proopiomelanocortin-expressing cells. We previously showed that human and murine mutations in the gene encoding this highly cortico/melanotrope-specific transcription factor cause a neonatal onset form of congenital isolated ACTH deficiency (IAD). We characterized the largest series of neonatal IAD patients caused by TPIT mutations, and this revealed a highly homogeneous clinical presentation. So far, 12 different loss-of-function TPIT mutations have been identified. The methionine 86 arginine (M86R) TPIT mutation was recently identified in compound heterozygosity with the 782delA frame-shift mutation in two siblings with early-onset IAD.
We conducted a functional analysis of the missense M86R mutation to assess transcriptional activity, DNA binding activity, and nuclear location, as well as protein-protein interactions.
Although the M86 residue is located within the T-box DNA-binding domain, it did not affect monomer DNA-binding activity per se, but it impaired DNA binding with other DNA-bound proteins, including itself (homodimers) and pituitary homeobox 1 (Pitx1). The M86 residue is at the interface between T domains in the T dimers crystal structure, and it appears that the same residue is involved in heterodimer formation with pituitary Pitx1. Furthermore, TPIT M86R is deficient in the recruitment of the coactivator SRC2 that partly mediates the CRH stimulation of proopiomelanocortin transcription.
Thus, the M86R TPIT mutation is defining an important surface of the T domain for multiple protein interactions and for transcription.
Tpit是一种T盒转录因子,对垂体促肾上腺皮质激素原表达细胞的终末分化很重要。我们之前表明,编码这种高度特异性于促肾上腺皮质激素/促黑素细胞的转录因子的基因发生的人类和小鼠突变会导致先天性孤立性促肾上腺皮质激素缺乏症(IAD)的新生儿发病形式。我们对由TPIT突变引起的最大系列新生儿IAD患者进行了特征分析,结果显示出高度一致的临床表现。到目前为止,已鉴定出12种不同的功能丧失性TPIT突变。最近在两名早发性IAD的兄弟姐妹中发现了甲硫氨酸86精氨酸(M86R)TPIT突变与782delA移码突变的复合杂合子。
我们对错义M86R突变进行了功能分析,以评估转录活性、DNA结合活性、核定位以及蛋白质-蛋白质相互作用。
尽管M86残基位于T盒DNA结合域内,但它本身并不影响单体DNA结合活性,但它会损害与其他DNA结合蛋白的DNA结合,包括其自身(同二聚体)和垂体同源盒1(Pitx1)。M86残基位于T二聚体晶体结构中T结构域之间的界面处,并且似乎相同的残基参与了与垂体Pitx1的异二聚体形成。此外,TPIT M86R在共激活因子SRC2的募集方面存在缺陷,SRC2部分介导促肾上腺皮质激素原转录的促肾上腺皮质激素释放激素刺激。
因此,M86R TPIT突变定义了T结构域的一个重要表面,用于多种蛋白质相互作用和转录。